HR 9774·Federal·house
To amend the Federal Food, Drug, and Cosmetic Act to provide for expedited approval of priority nonprescription drugs, and for other purposes.
In Committee
Sponsor: Rep. Latta, Robert E. [R-OH-5] (R)
Latest Action
Referred to the House Committee on Energy and Commerce.
Jul 20, 2026
Track this bill
Get real-time alerts when HR 9774 changes status, plus AI-powered summaries and stage predictions.
Sign up free